Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,845.00-1.52%ETH$2,446.04-0.38%GOLD$4,357.90-1.12%OIL$104.00+1.48%
Smart Investors Daily
IN

OTC · INBP

Integrated BioPharma, Inc.

Consumer Defensive · Packaged Foods

$0.18

Up+$0.00 (+0.00%)

Updated Sep 10, 2026, 11:04 PM

SID Score

3.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
9.58M
P/E ratio
14.26
Dividend yield
0.00%
52-week range
$0.14 – $0.42
Volume
705
Avg. volume
12.92K

Price performance

INBP price history

1M range · 11 trading sessions · Daily adjusted prices

INBP closed at $0.18 after 11 trading sessions, up 12.22% for the selected period.

Last close
$0.18
Period change
+12.22%
Period low
$0.16
Period high
$0.19
Daily close
View OHLC price history
INBP OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 28, 2026$0.1825$0.1825$0.18$0.18705
Aug 27, 2026$0.179$0.189$0.179$0.189900
Aug 26, 2026$0.175$0.175$0.175$0.1756.8K
Aug 25, 2026$0.173$0.174$0.173$0.174600
Aug 24, 2026$0.19$0.19$0.167$0.16738.04K
Aug 21, 2026$0.18$0.18$0.18$0.185K
Aug 19, 2026$0.1781$0.1781$0.1781$0.1781150
Aug 18, 2026$0.1793$0.1793$0.1793$0.1793100
Aug 17, 2026$0.1606$0.1606$0.16$0.1617.1K
Aug 14, 2026$0.1706$0.1706$0.1606$0.16811.03K
Aug 13, 2026$0.1696$0.1696$0.1604$0.1604800

Latest INBP news

The latest Smart Investors Daily articles mentioning INBP.

Stock researchCompany · Overview

INBP research

Overview

Company profile and research snapshot.

Company profile

INTEGRATED BIOPHARMA INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Dec 2, 2025

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions

LAUPHEIM, Germany and MARTINSRIED, Germany and MUNICH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Coriolis Pharma, a globally operating contract research and development organization (CRDO) and a leader in formulation research and development for biopharmaceuticals, today announced a strategic collaboration.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By